business
Healthcare stocks face uncertainty as Democrats take control of Congress
Healthcare stocks face uncertainty as Democrats prepare to take control of Congress amid potential legislative gridlock.
Key points
- Mizuho specialist Jared Holz predicts limited healthcare sector movement due to likely legislative gridlock.
- Pharmaceutical stocks are trading at higher valuations than technology for the first time in 20 years.
- The State Street Health Care Select ETF is up approximately 32% since January 2025.
Why it matters. Investors may need to adjust their portfolios by picking specific names rather than holding the entire sector while awaiting potential regulatory changes in the next couple of years.
Healthcare stocks face uncertainty as Democrats prepare to take control of Congress, according to Mizuho sector specialist Jared Holz. Holz told CNBC on Wednesday that the outlook remains unclear due to potential legislative gridlock and noted that pharmaceuticals are currently trading at higher valuations than technology for the first time in two decades.
Latest updates
Healthcare stocks face uncertainty as Democrats take control of Congress
Jared Holz, a healthcare sector specialist at Mizuho, stated that the outlook for the industry remains uncertain due to likely legislative gridlock between lawmakers. The firm's analyst noted that significant changes are unlikely to materialize in the immediate future as the new Congress settles into its role. Investors are now evaluating whether the political transition will lead to regulatory stagnation or unexpected policy shifts in the healthcare domain. This uncertainty has caused healthcare stocks to struggle to find upward momentum in recent trading sessions.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.

